References
- Potter D. E., Burke J. A. An in vivo model for dissociating α2-and DA2-adrenoceptor activity in an ocular adnexa: utility of the cat nictitating membrane preparation. Curr. Eye Res 1984; 3: 1289–1298
- Saller C. F., Salama A. I. Apomorphine enantiomers1 effects on dopamine metabolism: Receptor and non-receotor related actions. European J. Pharmacol 1986; 121: 181–188
- Jennewein H. W., Bruckwick E. A., Hanbauer I., Mierau J., Lovenberg W. Evidence for a specific effect of BHT 920, an azepine derivative, on tyrosine hvdroxylase in the dopaminersic system of the rat. European J. Pharmacol 1986; 123: 363–369
- Mekki Q. A., Hassan S. M., Turner P. Bromocriptine lowers intraocular pressure without affecting blood pressure. Lancet 1983; 1: 1250–1251
- Lustig A. Verstärkt Bromocriptine die Wirkung augeninnendrucksenkender Mittel. Dtsch. Med. Wochenschr 1983; 108: 1656–1657
- Mekki Q. A., Warrington S. J., Turner P. Bromocriptine eye drops lower intraocular pressure without affecting prolactin levels. Lancet 1984; 1: 287–288
- Mekki Q. A., Turner P. Stimulation of dopamine receptor (type 2) lowers human intraocular pressure. Br. J. Ophthalmol 1985; 69: 909–910
- Potter D. E., Burke J. A. Effects of ergoline derivatives on intraocular pressure and iris function in rabbits and monkeys. Curr. Eye Res. 1982-1983; 2: 281–288
- Potter D. E., Burke J. A., Chang F. W. Ocular hypotensive action of ergoline derivatives in rabbits: effects of sympathectomy and domperidone pretreatment. Curr. Eye Res 1984; 3: 307–314
- Potter D. E., Burke J. A., Chang F. W. Alteration in ocular function induced by phenylethylarnine analogs of dopamine. Curr. Eye Res 1984; 3: 851–859
- Siegel M. J., Lee P. Y., Podos S. M., Mittag T. W. Effect of topical pergolide on aqueous dynamics in normal and glaucomatous monkeys. Exp. Eye Res 1987; 44: 227–233
- Potter D. E., Burke J. A. Does B-HT920 lower intraocular pressure in cats by interacting with α2-and/or DA2-adrenoceptors. J. Ocular Pharmacol 1985; 1: 29–45
- Horn A. S., Tepper P., Van Der Weide J., Watanabe M., Griforiadis D., Seeman P. Synthesis and radioreceptor binding activity of N-0437, a new, extremely potent and selective D2 dopamine receptor agonist. Pharmaceutisch Weekblad Sci. Ed. 1985; 7: 208–211
- Beaulieu M., Itoh Y., Tepper P., Horn A. S., Kebabian J. W. N,N-Disubstituted 2-aminotetralins are potent D-2 dopamine receptor agonists. European J. Pharmacol 1984; 105: 15–21
- Potter D. E., Burke J. A. A potential dual mode of action for aminotetralins in 1owering intraocular pressure. Invest. Ophthalmol. Vis. Sci. (Suppl) 1986; 27: 289
- Rowland J. M., Potter D. E. The effects of topical prazosin on normal and elevated intraocular pressures and blood pressures in rabbits. European J. Pharmacol 1980; 64: 361–363
- Burke J. A., Potter D. E. Ocular effects of a relatively selective α2 agonist (UK-14,304–18) in cats, rabbits and monkeys. Curr. Eye Res 1986; 5: 665–675
- Van der Weide J., De Vries J. B., Tepper P. G., Horn A. S. In vitro binding of the very potent and selective D-2 dopamine agonist [3h]N-0437 to calf caudate membranes. European J. Pharmacol 1987; 134: 211–219
- Wilson S. P., Unsworth C. D., Viveros O. H. Regualtion of opioid peptide synthesis and processing in adrenal chromaffin cells by catecholamines and cyclic adenosine 3′:5′-monophosphate. J. Neurosci 1984; 4: 2993–3001
- Waggoner W. G., McDermed J., Leighton H. J. Presynaptic regulation of tyrosine hydroxylase activity in rat striatal synaptosomes by doparnine analogs. Mol. Pharmacol 1980; 18: 91–99, 1980